应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02359 药明康德
已收盘 12-05 16:09:08
103.000
+0.300
+0.29%
最高
104.000
最低
101.800
成交量
797.93万
今开
102.700
昨收
102.700
日振幅
2.14%
总市值
3,074亿
流通市值
525.79亿
总股本
29.84亿
成交额
8.21亿
换手率
1.56%
流通股本
5.10亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通港股通持股解析|12月5日
智通财经 · 08:30
智通港股通持股解析|12月5日
港股药明系短线拉升!药明生物涨近7%,药明合联涨超4%
老虎资讯综合 · 12-04 14:36
港股药明系短线拉升!药明生物涨近7%,药明合联涨超4%
港股异动 | CRO概念股午后快速拉升 药明生物(02269)涨超7% 机构建议关注行业整合趋势
智通财经 · 12-04 14:35
港股异动 | CRO概念股午后快速拉升 药明生物(02269)涨超7% 机构建议关注行业整合趋势
医药股普遍回暖 荣昌生物(09995)涨4.26% 交银国际料明年内地医药板块稳中向好态势延续
金吾财讯 · 12-04 10:58
医药股普遍回暖 荣昌生物(09995)涨4.26% 交银国际料明年内地医药板块稳中向好态势延续
【券商聚焦】中泰国际:北京与上海相继出台政策支持创新医疗器械的开发 料有利于创新医疗器械板块发展
金吾财讯 · 12-04 09:04
【券商聚焦】中泰国际:北京与上海相继出台政策支持创新医疗器械的开发 料有利于创新医疗器械板块发展
智通AH统计|12月3日
智通财经 · 12-03 16:15
智通AH统计|12月3日
药明康德(603259)披露截至11月30日证券变动月报表,12月2日股价下跌3.12%
证券之星 · 12-02 22:00
药明康德(603259)披露截至11月30日证券变动月报表,12月2日股价下跌3.12%
无锡药明康德(02359、603259)2025年11月股份变动月报:股本维持不变
公告速递 · 12-02
无锡药明康德(02359、603259)2025年11月股份变动月报:股本维持不变
每日卖空追踪 | 药明康德 12月01日卖空量成交19.21万股,卖空比例为3.87%
市场透视 · 12-01
每日卖空追踪 | 药明康德 12月01日卖空量成交19.21万股,卖空比例为3.87%
智通AH统计|12月1日
智通财经 · 12-01
智通AH统计|12月1日
景顺长城权益困局:明星基金经理光环褪色,中生代难扛大旗
博望财经 · 12-01
景顺长城权益困局:明星基金经理光环褪色,中生代难扛大旗
药明康德7年12倍回报背后:被认可的长期价值
商业观察 · 12-01
药明康德7年12倍回报背后:被认可的长期价值
2025年司美格鲁肽原料药竞争格局
药事纵横 · 11-30
2025年司美格鲁肽原料药竞争格局
智通港股空仓持单统计|11月28日
智通财经 · 11-28
智通港股空仓持单统计|11月28日
智通AH统计|11月28日
智通财经 · 11-28
智通AH统计|11月28日
无惧市场波动噪音,药明康德的长期价值根基稳固
DoNews · 11-27
无惧市场波动噪音,药明康德的长期价值根基稳固
智通港股沽空统计|11月27日
智通财经 · 11-27
智通港股沽空统计|11月27日
摩根大通增持药明康德(02359)约73.65万股 每股作价约102.49港元
智通财经 · 11-26
摩根大通增持药明康德(02359)约73.65万股 每股作价约102.49港元
11月26日港股药品及生物科技行业沽空数据盘点,药明康德、石药集团、京东健康沽空金额位居行业前三
证券之星APP · 11-26
11月26日港股药品及生物科技行业沽空数据盘点,药明康德、石药集团、京东健康沽空金额位居行业前三
研报点睛:涨幅居前!关注这一赛道
东方财富研究中心 · 11-26
研报点睛:涨幅居前!关注这一赛道
加载更多
公司概况
公司名称:
药明康德
所属市场:
SEHK
上市日期:
--
主营业务:
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格:
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":103,"timestamp":1764922148005,"preClose":102.7,"halted":0,"volume":7979327,"delay":0,"floatShares":510476909,"shares":2984000000,"eps":3.021157946067136,"marketStatus":"已收盘","change":0.3,"latestTime":"12-05 16:09:08","open":102.7,"high":104,"low":101.8,"amount":820611322,"amplitude":0.021422,"askPrice":103,"askSize":57900,"bidPrice":102.9,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":5.126565070997073,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":102.7,"dividendRate":0.014113,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.262364,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":90.4,"timestamp":1764918000000,"preClose":89.59,"halted":0,"volume":38458100,"delay":0,"premium":"+3.45"}},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2589856915","title":"智通港股通持股解析|12月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2589856915","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589856915?lang=zh_cn&edition=full","pubTime":"2025-12-05 08:30","pubTimestamp":1764894602,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,根据2025年12月4日披露数据,中国电信、绿色动力环保、昊天国际建投位居港股通持股比例前3位,分别为72.75%、69.12%、68.59%。此外,阿里巴巴-W、美团-W、泡泡玛特在最近有统计数据的5个交易日内,持股额增幅最大,分别为+36.91亿元、+19.48亿元、+12.39亿元;紫金矿业、中芯国际、中国移动在最近有统计数据的5个交易日内,持股额减幅最大,分别为-11.62亿元、-9.24亿元、-4.58亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01635","03143","PNGAY","00762","01375","01138","01798","02899","02318","03968","80883","000002","80992","00939","LNVGY","00956","02628","06869","00728","02359","01330","01456","HMTD.SI","01288","09992","01065","00992","03033","601318","01801","01776","03958","02238","03145","HPAD.SI","LU0326950275.SGD","PAImain","01341","01088","01108","02202","82318","MPNGY","03690","00941","03678","00883"],"gpt_icon":1},{"id":"1114177897","title":"港股药明系短线拉升!药明生物涨近7%,药明合联涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114177897","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114177897?lang=zh_cn&edition=full","pubTime":"2025-12-04 14:36","pubTimestamp":1764830175,"startTime":"0","endTime":"0","summary":"药明系短线拉升,$药明生物(02269)$涨近7%,$药明合联(02268)$涨超4%,$药明康德(603259)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","02269","02268"],"gpt_icon":0},{"id":"2588005894","title":"港股异动 | CRO概念股午后快速拉升 药明生物(02269)涨超7% 机构建议关注行业整合趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2588005894","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588005894?lang=zh_cn&edition=full","pubTime":"2025-12-04 14:35","pubTimestamp":1764830137,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股午后快速拉升,截至发稿,药明生物涨4.94%,报32.28港元;金斯瑞生物科技涨3.8%,报15.01港元;药明康德涨2.62%,报99.95港元;泰格医药涨1.22%,报38.04港元。消息面上,药明生物12月2日宣布,已与卡塔尔自由区管理局签署战略合作备忘录,将全球服务网络与专业业务能力拓展至中东地区。此次战略合作为药明生物在卡塔尔自由区打造其在中东地区首个一体化CRDMO中心奠定了基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8ece981a1ccfcd1a76894a7d36bcad57","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0052750758.USD","LU1720050803.USD","LU0307460666.USD","LU0708995583.HKD","LU0516423091.SGD","HK0000320223.HKD","LU0348825331.USD","LU0819121731.USD","LU0043850808.USD","HK0000320264.USD","LU0140636845.USD","LU2039709279.SGD","BK1589","03347","LU0516422440.USD","LU1880383366.USD","LU0327786744.USD","LU1242518931.SGD","LU0359201612.USD","SG9999002562.SGD","BK1521","LU0359202008.SGD","LU2242644610.SGD","LU0181495838.USD","LU0456846285.SGD","LU0051755006.USD","LU0823426480.USD","LU0516422366.SGD","LU3063872942.SGD","LU0320764599.SGD","02359","LU0572944931.SGD","LU1688375341.USD","LU0417516902.SGD","LU0456827905.SGD","HK0000306685.HKD","LU1242518857.USD","LU0823426308.USD","LU2045819591.USD","01548","LU0417516738.SGD","LU2125910500.SGD","LU1794554557.SGD","SG9999002463.SGD","IE00B0JY6N72.USD","02269","LU0326950275.SGD","LU1046422090.SGD","BK1583","LU0516423174.USD"],"gpt_icon":0},{"id":"2588074906","title":"医药股普遍回暖 荣昌生物(09995)涨4.26% 交银国际料明年内地医药板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2588074906","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588074906?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:58","pubTimestamp":1764817092,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股普遍回暖,荣昌生物 涨4.26%,康方生物涨3.89%,金斯瑞生物科技涨3.11%,康诺亚-B涨2.95%,科伦博泰生物-B涨2.45%,诺诚健华涨1.79%,药明生物涨1.63%,泰格医药涨1.38%,药明康德涨1.33% 。交银国际发表报告指,予内地医药行业领先评级。如该行此前预期,内地医药行业2025年迎来关键转折。2026年,该行认为板块稳中向好态势延续,但影响市场表现的核心因素或呈分化态势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970883","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU0516422952.EUR","IE00BPRC5H50.USD","09926","LU0819121731.USD","03329","HK0000320264.USD","LU2399975544.HKD","LU0634319403.HKD","BK1610","LU1720050803.USD","688331","LU2242644610.SGD","LU0359201612.USD","LU0516423091.SGD","LU2148510915.USD","LU0181495838.USD","02162","BK1574","LU0823426308.USD","LU1688375341.USD","LU1961090484.USD","LU0856984785.SGD","09969","LU2039709279.SGD","BK0239","LU2488822045.USD","BK1589","LU0561508036.HKD","02269","159938","LU0052750758.USD","BK1141","LU0359202008.SGD","BK1587","09939","LU1880383366.USD","02359","06990","LU0326950275.SGD","03347","09995","BK1161","LU0307460666.USD","01548","LU2328871848.SGD","LU2476274720.SGD","LU0417516571.SGD","LU1046422090.SGD","BK1515"],"gpt_icon":0},{"id":"2588076380","title":"【券商聚焦】中泰国际:北京与上海相继出台政策支持创新医疗器械的开发 料有利于创新医疗器械板块发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2588076380","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588076380?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:04","pubTimestamp":1764810245,"startTime":"0","endTime":"0","summary":"医疗器械板块上涨,该机构估计是由于北京与上海相继出台政策支持创新医疗器械开发。北京出台《北京市促进医疗器械产业高质量发展若干措施》,提出多条举措支持创新器械的临床研发、注册上市、销售推广、产业链发展和出海。该机构认为以上政策有利于创新医疗器械板块的发展,但港股大型创新医疗器械生产商不多,该机构对传统医疗器械生产商的2025年业绩偏谨慎。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970861","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","LU0140636845.USD","159883","LU0819121731.USD","BK1191","LU2097828714.EUR","LU1969619763.USD","LU2242644610.SGD","LU0456827905.SGD","09997","01801","LU0051755006.USD","LU0359201612.USD","LU0456846285.SGD","LU0516423091.SGD","IE00BZ08YT58.USD","LU2097828631.EUR","LU2097828474.EUR","BK1574","BK1583","01177","LU0823426308.USD","LU0173614495.USD","LU2097828805.USD","LU3063872942.SGD","LU0856984785.SGD","LU2039709279.SGD","09996","LU0348825331.USD","LU0348735423.USD","HK0000165453.HKD","LU2488822045.USD","BK1100","02269","LU0516423174.USD","BK1141","LU2045819591.USD","LU0359202008.SGD","LU0708995583.HKD","LU1880383366.USD","LU0455707207.USD","02359","LU2125910500.SGD","BK1161","LU0823426480.USD","LU0307460666.USD","SG9999002463.SGD","03692","IE00B0JY6N72.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2588101655","title":"智通AH统计|12月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588101655","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588101655?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止12月3日收盘,东北电气、弘业期货、中石化油服分列AH溢价率前三位,溢价率分别为900.00%、276.85%、265.79%;宁德时代、招商银行、恒瑞医药分列AH溢价率末三位,溢价率分别为-4.88%、-0.25%、1.71%。其中广和通、东北电气、晨鸣纸业的偏离值位居前三,分别为49.00%、36.60%、26.74%;另外,广汽集团、均胜电子、江苏宁沪高速公路的偏离值位居后三,分别为-26.76%、-18.54%、-15.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03606","IE00BVYPNQ40.USD","LU0314109678.HKD","00300","00187","LU0828237510.HKD","00995","LU0214875030.USD","02899","00916","06066","159982","399300","IE00BZ18W340.USD","LU0791590937.USD","02238","00553","01988","03143","BK1583","00638","01276","02338","02359","03678","01033","02866","01349","03968","LU2125910500.SGD","00177","01812","00670","06031","00317","00548","00699","00719","LU1880383366.USD","01330","BK1582","03750","01057","00753","01635","01108","LU0370786039.SGD","00042","02218"],"gpt_icon":1},{"id":"2588087056","title":"药明康德(603259)披露截至11月30日证券变动月报表,12月2日股价下跌3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588087056","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588087056?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:00","pubTimestamp":1764684054,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘,药明康德报收于89.42元,较前一交易日下跌3.12%,最新总市值为2668.08亿元。该股当日开盘92.03元,最高92.18元,最低89.19元,成交额达39.04亿元,换手率为1.75%。公司近日发布公告,披露了截至2025年11月30日的证券变动月报表。公告显示,无锡药明康德新药开发股份有限公司H股和A股的法定/注册股本、已发行股份均无变动。H股总数为510,476,909股,于香港联交所上市;A股总数为2,473,280,246股,于上海证券交易所上市。本月底注册股本总额为人民币2,983,757,155元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200038977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1046422090.SGD","LU1979443071.USD","LU0052750758.USD","LU2045819591.USD","BK0216","LU2125910500.SGD","BK1583","LU1934453819.USD","LU1997244956.HKD","LU1997245094.SGD","603259","LU1997245177.USD","LU0320764599.SGD","02359","LU1808992512.USD","LU2495084118.USD","LU2488822045.USD","BK1576","LU2242644610.SGD","LU2328871848.SGD","LU1969619763.USD","161027","BK1141","LU0708995583.HKD","LU0456842615.SGD"],"gpt_icon":0},{"id":"1199540818","title":"无锡药明康德(02359、603259)2025年11月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1199540818","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199540818?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:37","pubTimestamp":1764664671,"startTime":"0","endTime":"0","summary":"无锡药明康德新药开发股份有限公司于2025年12月2日发布2025年11月股份变动月报表。截至2025年11月30日,公司在香港联交所上市的H股证券代码为02359,在上海证券交易所上市的A股证券代码为603259。公司报告期内H股已发行股本总数为510,476,909股,A股已发行股本总数为2,473,280,246股,均与上月持平。公司当月未发生任何新增发行、购回、注销或库藏股变动,股本结构保持稳定。本次公告由联席公司秘书张月芬签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"gpt_icon":0},{"id":"2588470695","title":"每日卖空追踪 | 药明康德 12月01日卖空量成交19.21万股,卖空比例为3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588470695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588470695?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577829,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月01日,涨0.99%,卖空量成交19.21万股,较上一交易日减少61.83%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163417a71c71c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163417a71c71c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","BK1141","BK1583","02359","LU0320764599.SGD","LU2242644610.SGD","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","BK1576","LU0052750758.USD"],"gpt_icon":0},{"id":"2588476777","title":"智通AH统计|12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588476777","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588476777?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576905,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止12月1日收盘,东北电气、弘业期货、中石化油服分列AH溢价率前三位,溢价率分别为881.82%、274.55%、269.74%;宁德时代、招商银行、恒瑞医药分列AH溢价率末三位,溢价率分别为-5.03%、-1.36%、1.50%。其中广和通、大众公用、京城机电股份的偏离值位居前三,分别为31.56%、23.38%、20.11%;另外,江苏宁沪高速公路、均胜电子、中国人寿的偏离值位居后三,分别为-13.73%、-12.81%、-11.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03143","LU0918141887.USD","03750","00317","00914","IE0008368742.USD","01812","LU0164865239.USD","LU0918141705.HKD","02648","00548","00719","00177","159982","LU0456854461.SGD","03678","03606","02218","02338","02359","BK1185","01635","00670","00187","01276","399300","00699","01349","00553","02628","01057","02899","IE00BZ18W456.USD","LU1769817096.USD","06066","BK1567","BK1184","01072","00300","00995","00638","BK1123","00753","01108","01033","01055","00042","01988","03968"],"gpt_icon":1},{"id":"2588776172","title":"景顺长城权益困局:明星基金经理光环褪色,中生代难扛大旗","url":"https://stock-news.laohu8.com/highlight/detail?id=2588776172","media":"博望财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588776172?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:12","pubTimestamp":1764576746,"startTime":"0","endTime":"0","summary":"虽然药明康德年内涨幅约为70%仍是十大重仓股中最好的标的,但是显然刘彦春的介入时机是错误的。换一个角度,从公司主动权益类基金经理在管产品数量来看,管理数量最多的并不是知名度排在前两位的刘彦春和杨锐文,而是接管了当初“三哥”鲍无可多只产品的邹立虎。综上所述,换一个角度来看,当鲍无可离开,刘彦春、杨锐文渐渐老去实力下降时,这对于景顺长城的中生代乃至新生代基金经理来说,机会与挑战同在!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161459a71c6538&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161459a71c6538&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00300","02359","IE00B0169L03.USD","LU1993786604.SGD","BK1214","LU1960683339.HKD","01880","LU1807302812.USD"],"gpt_icon":0},{"id":"2588982706","title":"药明康德7年12倍回报背后:被认可的长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2588982706","media":"商业观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588982706?lang=zh_cn&edition=full","pubTime":"2025-12-01 14:35","pubTimestamp":1764570935,"startTime":"0","endTime":"0","summary":"如果从药明康德上市第一天就拿稳股票,截止到今年9月,投资者可以获得12.3倍的投资回报率。截至今年上半年,药明康德的持续经营业务在手订单与2018年时相比已经实现了38%的复合增长率,目前已逼近600亿。药明康德对股东的回馈同样不可忽视。2025年,药明康德已实施近70亿元股东回报计划,累计回馈股东总金额更是占到2024年净利润的72%。随着核心业务盈利持续增长,药明康德2025年前三季度归母净利润达120.76亿元,同比增长84.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201145248a4c516be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201145248a4c516be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0052750758.USD","BK1576","LU2125910500.SGD","LU0320764599.SGD","02359","LU1046422090.SGD","BK1141","LU2242644610.SGD","LU0708995583.HKD","LU2045819591.USD"],"gpt_icon":0},{"id":"2587798947","title":"2025年司美格鲁肽原料药竞争格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2587798947","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587798947?lang=zh_cn&edition=full","pubTime":"2025-11-30 08:03","pubTimestamp":1764461017,"startTime":"0","endTime":"0","summary":"图:国家药品监督管理局进入2025年,随着多条产线陆续投产与扩产计划落地,我国司美格鲁肽原料药产能正迎来集中释放期。本文将系统梳理当前国内主要企业的现有产能、扩建进展及未来规划,全景呈现2025年司美格鲁肽原料药的产能格局。瀚宇药业计划在2025年将司美格鲁肽原料药产能提升至5-10吨/年,是目前规划最为激进的企业之一。总 结总体来看,国内司美格鲁肽原料药的产能布局已然铺开,这场围绕GLP-1赛道的投入无疑是坚决的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251130080702a4c2ca18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251130080702a4c2ca18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821","02359"],"gpt_icon":0},{"id":"2586785109","title":"智通港股空仓持单统计|11月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586785109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586785109?lang=zh_cn&edition=full","pubTime":"2025-11-28 18:30","pubTimestamp":1764325805,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止11月21日,未平仓空单比位列前三位为万科企业、中远海控、恒瑞医药,空仓比分别为19.60%、16.49%、16.36%。未平仓空单比(绝对值)较上一次增加最多为中环新能源、万科企业、东方电气,分别增加2.58%、1.92%、1.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0561508036.HKD","06821","LU0650527681.SGD","PAImain","LU1770034418.SGD","02382","01276","HPAD.SI","IE00BZ08YT58.USD","03759","00763","000002","BK1507","PNGAY","01072","601318","82318","03888","02899","LNVGY","LU0918141887.USD","01428","01735","80992","LU1807302812.USD","06613","02228","01919","02318","02498","06680","LU0880133367.SGD","LU1794554557.SGD","09696","00992","01951","LU0630378692.HKD","LU1303224171.USD","01910","03145","LU0348805143.USD","LU0287142896.SGD","02202","LU0588545490.SGD","03800","01635","02359"],"gpt_icon":1},{"id":"2586320425","title":"智通AH统计|11月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586320425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586320425?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:15","pubTimestamp":1764317706,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止11月28日收盘,东北电气、弘业期货、中石化油服分列AH溢价率前三位,溢价率分别为864.29%、270.78%、268.92%;宁德时代、招商银行、恒瑞医药分列AH溢价率末三位,溢价率分别为-5.29%、-1.61%、0.75%。其中广和通、大众公用、山东新华制药股份的偏离值位居前三,分别为23.08%、22.85%、20.46%;另外,广汽集团、中国南方航空股份、江苏宁沪高速公路的偏离值位居后三,分别为-15.57%、-12.01%、-10.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0329678337.USD","00177","01812","01880","02866","03678","01988","03968","399300","00187","00638","LU1048596156.SGD","LU0359201612.USD","01033","03750","00753","01276","02359","IE00BZ08YT58.USD","00042","01055","06066","LU0463099449.HKD","01528","LU0502904849.HKD","01057","02603","00317","02579","02628","02238","BK1552","01349","159982","01108","01635","LU0738912210.USD","00300","IE00B3M56506.USD","02899","01072","03143","06818","00719","02338","06031","00895","00553","02218"],"gpt_icon":1},{"id":"2586627224","title":"无惧市场波动噪音,药明康德的长期价值根基稳固","url":"https://stock-news.laohu8.com/highlight/detail?id=2586627224","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586627224?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:00","pubTimestamp":1764230431,"startTime":"0","endTime":"0","summary":"近期,药明康德持续受到资本市场关注,一系列股东减持与资产优化举措引发了市场讨论。10月29日,药明康德发布公告称,17家股东因自身资金需求计划减持不超过公司总股本2%的A股股份,比例可控。从药明康德此次减持计划的披露情况来看,整个过程符合监管要求,规范且透明。展望未来,药明康德的长期发展前景根基是稳固的。在生物医药全球分工不可逆转的大趋势下,药明康德深厚的技术积累与完善的全球布局构筑了坚实壁垒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127160813a4bd9d97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127160813a4bd9d97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","LU2242644610.SGD","LU1046422090.SGD","LU0708995583.HKD","LU2125910500.SGD","LU0052750758.USD","LU2045819591.USD","BK1141","02359","BK1583"],"gpt_icon":1},{"id":"2586038299","title":"智通港股沽空统计|11月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586038299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586038299?lang=zh_cn&edition=full","pubTime":"2025-11-27 08:20","pubTimestamp":1764202829,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,吉利汽车-R、快手-WR、京东健康-R上一交易日沽空比率位于前三位,分别为100.00%、100.00%、100.00%。阿里巴巴-SW、美团-W、小米集团-W的沽空金额位居前三,分别为37.68 亿元、22.72 亿元、15.84 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GELYY","09988","LU","00175","02359","03690","82318","601318","002594","EVS.SI","80020","HYDD.SI","06618","03360","02318","HXXD.SI","01776","01024","KSTmain","MPNGY","01299","80291","ALBmain","PAImain","89888","HMTD.SI","HPAD.SI","81211","METmain","80175","81810","86618","MIUmain","80941","HTCD.SI","03968","00357","00639","TCHmain","01810","BABA","82388","81024","81299","03145"],"gpt_icon":1},{"id":"2586259735","title":"摩根大通增持药明康德(02359)约73.65万股 每股作价约102.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586259735","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586259735?lang=zh_cn&edition=full","pubTime":"2025-11-26 19:24","pubTimestamp":1764156293,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,11月21日,摩根大通增持药明康德(02359)73.6509万股,每股作价102.4881港元,总金额约为7548.34万港元。增持后最新持股数目约为2572.02万股,持股比例为5.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211327993.USD","LU2756315318.SGD","LU1551013425.SGD","IE00BZ1G4Q59.USD","LU0106831901.USD","LU0417517546.SGD","BK0216","LU2125910500.SGD","LU1363072403.SGD","LU1934453819.USD","LU2746668461.USD","LU1997244956.HKD","LU2430703251.USD","LU2023250330.USD","LU0251132253.USD","BK4533","IE00BBT3K403.USD","IE00B775SV38.USD","603259","LU0265550946.USD","LU0149725797.USD","LU1629891620.HKD","BK4581","LU2242649171.HKD","LU0106261372.USD","LU2746668974.SGD","02359","LU2495084118.USD","LU2211815571.USD","SG9999002232.USD","LU0971096721.USD","IE00BLSP4452.SGD","LU1917777945.USD","LU2462157665.USD","LU0211328371.USD","LU1244550221.USD","LU2430703095.HKD","LU1244550494.USD","LU1969619763.USD","LU2430703178.SGD","SG9999002224.SGD","LU1720051017.SGD","BK4534","LU0882574139.USD","LU0964807845.USD","BK1141","IE00BYXW3230.USD","LU0708995583.HKD","LU0320765489.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2586295801","title":"11月26日港股药品及生物科技行业沽空数据盘点,药明康德、石药集团、京东健康沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2586295801","media":"证券之星APP","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586295801?lang=zh_cn&edition=full","pubTime":"2025-11-26 18:05","pubTimestamp":1764151554,"startTime":"0","endTime":"0","summary":"证券之星消息,11月26日港交所披露数据显示,当日港股药品及生物科技行业的159只个股中有82只被沽空,总沽空股数为1.43亿股,总沽空金额为24.9亿元(港元),而当日药品及生物科技行业的总成交金额为142.25亿元(港元),沽空比例为17.5%。当日药品及生物科技行业总体涨1.03%。从沽空金额来看,药明康德、石药集团、京东健康沽空金额位居行业前三,分别为4.03亿港元、3.5亿港元、3.37亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126181241a712be4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126181241a712be4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU0140636845.USD","BK1589","HK0000165453.HKD","LU0314109678.HKD","LU1960683339.HKD","LU2125910500.SGD","BK1142","BK1247","BK1515","LU0456827905.SGD","SGXZ62798434.SGD","LU1226288253.USD","LU1328277881.USD","LU0501845795.SGD","LU1226287792.SGD","LU1226288170.HKD","LU1993786604.SGD","LU1807302812.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU0880133367.SGD","BK1571","SGXZ86797644.SGD","IE0008368742.USD","LU1152091754.HKD","IE0008369823.USD","SG9999004220.SGD","02359","LU1226287529.USD","LU0326950275.SGD","86618","LU0315179316.USD","BK1591","LU1008478684.HKD","LU0052750758.USD","LU1226287875.USD","IE00B031HY20.USD","LU0320764599.SGD","06618","LU0051755006.USD","LU0067412154.USD","01093","IE00B5MMRT66.SGD","LU1046422090.SGD","LU1152091168.USD","BK1576","LU0072913022.USD","BK1521"],"gpt_icon":0},{"id":"2586260666","title":"研报点睛:涨幅居前!关注这一赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260666","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586260666?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:35","pubTimestamp":1764149725,"startTime":"0","endTime":"0","summary":"11月26日,A股三大指数今日涨跌不一,截止收盘,沪指跌0.15%,收报3864.18点;深证成指涨1.02%,收报12907.83点;创业板指涨2.14%,收报3044.69点。国金证券表示,CGT 等前沿创新,或迎监管更多支持;数据生态新赛道,隐藏未来新金矿。颠覆性创新技术赛道的布局,将是未来药企制胜要地。新一代技术的细胞基因疗法、AI制药等前沿赛道,或是2026年新热点。医药医疗数据要素相关企业,值得药企布局和资本市场关注与投资。国泰海通表示,持续推荐创新药械及产业链。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126174028a4bb8740&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126174028a4bb8740&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02615","03347","LU0359201885.HKD","LU0359201612.USD","02359","LU1023057109.AUD","01276","06160","BK1191","LU2543165471.USD","06990","LU0359202008.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":0.025},{"period":"3month","weight":-0.0929},{"period":"6month","weight":0.4565},{"period":"1year","weight":1.0523},{"period":"ytd","weight":0.8652}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.012449},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.006618},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.010471},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.714286,"avgChangeRate":0.043884}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}